Clinical Trial Update: Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PET [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating practice effects and amyloid imaging using 18F-PIB or Flutemetamol PET and FDG-PET in Alzheimer's disease has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: University of Utah | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-01-11